ORENCIA 125 mg/mL
abatacept · INJECTION, SOLUTION · E.R. Squibb & Sons, L.L.C.
No Recall History
Plain English
ORENCIA is a injection, solution containing abatacept at 125 mg/mL, taken subcutaneous. Manufactured by E.R. Squibb & Sons, L.L.C..
Key Facts
- Brand Name
- ORENCIA
- Generic Name
- abatacept
- NDC Code (Product)
0003-2188- Manufacturer
- E.R. Squibb & Sons, L.L.C.
- Strength
- 125 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125118
- Drug Class
- Selective T Cell Costimulation Modulator [EPC]
- Marketing Start
- 07/29/2011
Recall History
No Recall HistoryFrequently Asked Questions
What is ORENCIA used for?
ORENCIA contains abatacept. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is ORENCIA a controlled substance?
ORENCIA is not classified as a controlled substance by the DEA.
What is the generic name for ORENCIA?
The generic name for ORENCIA is abatacept. There are no other listed brand versions of abatacept.
What is the NDC code for ORENCIA 125 mg/mL?
The NDC (National Drug Code) for ORENCIA 125 mg/mL is 0003-2188, listed by E.R. Squibb & Sons, L.L.C..
Other ORENCIA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)